Minovivax 2% solution of the scalp 100ml


Sale price £18.99 Regular price £25.00

Tax included. Shipping calculated at checkout.
  • Minovivax. Androgenetic alopecia is a serious problem for many people, both men and women. Regardless of gender solution can be Minovivax medicinal product in the form of a 2% solution of the scalp, which comprises minoxidil.

Active substance: minoxidil (1 ml solution for skin contains 20mg minoxidil) and ingredients: propylene glycol, anhydrous ethanol and purified water.

Minoxidil is the active ingredient contained in a medicinal product Minovivax 2%. It affects hair growth by stimulating proliferation of hair follicles in growth phase. Additionally, reverses or suppresses follicle miniaturization. The effects are noticeable after two months, is limited hair loss, and after four months shows the increased hair growth.

The medicinal product Minovivax 2% solution of the scalp indicated for use in the treatment of androgenetic alopecia adults.

Additional information:
Keep out of reach of children, at room temperature.

Do not use in case of hypersensitivity to any component of the solution and during anticancer therapy (cytostatic), in the case of hair loss, which is the result of improper diet, discontinuation of hormonal contraceptives, improper care, as well as in case of a damaged scalp (burns, ulcers , scar tissue). Do not use the hair loss after giving birth, as well as during pregnancy or breast-feeding. Do not use in children.

For topical use on the scalp. Before treatment is unnecessary to consult your doctor, especially when the cause of hair loss is not known. Apply to dry scalp and hair. Once applied 1ml preparation to receive the dose to be 6 times press the pump. The solution should be applied to the central part of the area covered by the amendments, and then spread it with your fingertips. Repeat this twice a day, morning and evening. The maximum daily dose is 2 ml, must not be exceeded. Basically, after 12 months of regular application, you can expect maximum results.